-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies: Poster II

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Alexandre Bazinet, MD1*, Hagop M. Kantarjian, MD2, Gautam Borthakur, MD3, Musa Yilmaz, MD3*, Prithviraj Bose, MD4, Elias Jabbour5, Yesid Alvarado Valero, MD3, Kelly S. Chien, MD3, Naveen Pemmaraju, MD6, Koichi Takahashi, MD, PhD3, Nicholas J. Short, MD3, Naval Daver, MD3, Ghayas C. Issa7, Nitin Jain, MD3, Danielle E. Hammond, MD3, Debra Bull-Linderman, RN1*, Courtney D. DiNardo, MD, MSc3, Jan A. Burger, MD, PhD 8, Alessandra Ferrajoli, MD3, Guillermo Montalban-Bravo, MD4, Koji Sasaki, MD2, Guillermo Garcia-Manero, MD6, Farhad Ravandi, MD, MBBS9 and Tapan M. Kadia, MD3

1Department of Leukemia, MD Anderson Cancer Center, Houston, TX
2Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
8MD Anderson Cancer Center, Houston, TX
9University of Texas- MD Anderson Cancer Center, Houston, TX

Jitesh Kawedia, BPharm1*, Caitlin R Rausch, PharmD2*, Xiaoqian Li, PhD3*, Courtney D. DiNardo, MD, MSc2, Farhad Ravandi, MD, MBBS4, Naval Daver, MD2, Gautam Borthakur, MD2, Naveen Pemmaraju, MD2, Patrick K Reville, MD, MPH2, Nicholas J. Short, MD2, Elias Jabbour5, Guillermo Garcia-Manero, MD2,6,7, Hagop M. Kantarjian, MD2 and Tapan M. Kadia, MD2

1Pharmacy, Univ. of Texas, MD Anderson Cancer Ctr., Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
4University of Texas- MD Anderson Cancer Center, Houston, TX
5University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7University of Texas MD Anderson Cancer Center, Houston, TX

Adriano Venditti, MD1, Jing-Zhou Hou2, Pierre Fenaux, MD, PhD3, Brian A. Jonas, MD, PhD4, Radovan Vrhovac5*, Pau Montesinos, PhD, MD6*, Jacqueline S. Garcia, MD7, David Rizzieri8*, Michael Thirman9, Stanley Kotey10*, Jalaja Potluri11, Mazaher Dhalla10* and Vinod Pullarkat, MD12

1Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
2Hematology and BMT, Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA
3Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
4Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
5Department of Haematology, University Hospital Centre Zagreb, and University of Zagreb School of Medicine, Zagreb, Croatia
6Hospital Universitari i Politecnic la Fe, Valencia, Spain
7Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
8Novant Health Cancer Institute, Winston Salem, NC
9Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
10AbbVie Inc., North Chicago, IL
11AbbVie Inc, North Chicago, IL
12Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

Jules Higué1*, Pierre-Yves Dumas, MD, PhD2*, Laetitia Largeaud3*, Audrey Bidet, MD4*, Émilie Klein, MD5*, Olivier Mansier, PharmD, PhD6*, Lucie Rigolot7*, Eric Delabesse, MD, PhD8*, Anne Banos, MD9*, Suzanne Tavitian10*, Thibaut Leguay, MD11*, Sarah Guenounou, MD7*, Edouard Forcade, MD, PhD12*, Sarah Bertoli13*, Arnaud Pigneux, MD, PhD2* and Christian Recher, MD, PhD14*

1Service d'Hematologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
2Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
3Laboratoire d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
4Laboratoire d’Hématologie Biologique, CHU Bordeaux, Bordeaux, France
5Service Hématologie Biologique, CHU Bordeaux, Bordeaux, France
6Service Hématologie biologique, CHU Bordeaux, PESSAC, FRA
7CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
8IUCT-Oncopole, Hematology Laboratory, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
9Centre Hospitalier De Bayonne, Bayonne, FRA
10Service d’Hematologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
11Hematology, CHU Bordeaux, BORDEAUX, France
12Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France
13IUCT-Oncopole, Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
14Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France

Jorge Cortes, MD1, Joseph Jurcic, MD2, Maria R. Baer, MD3, William Blum, MD4, P. Brent Ferrell Jr., MD5, Brian A. Jonas, MD, PhD6, Sangmin Lee, MD7, Alice Mims, MD8, Shyam Ajay Patel, MD, PhD9*, Gary J. Schiller, MD10, Jay Yang, MD11 and Justin M. Watts, MD12

1Georgia Cancer Center, Augusta University, Augusta, GA
2Columbia University Medical Center, New York, NY
3Department of Medicine, University of Maryland School of Medicine, Baltimore, MD
4Winship Cancer Institute of Emory University, Atlanta, GA
5Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
6Department of Internal Medicine, Division of Malignant Hematology, Cellular Therapy and Transplantation, University of California Davis School of Medicine, Sacramento, CA
7Weill Cornell Medical Center, New York, NY
8Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
9Department of Medicine - Division of Hematology/Oncology, UMass Chan Medical School, Shrewsbury, MA
10Hematological Malignancy/ Stem Cell Transplant Program, David Geffen School of Medicine, UCLA, Los Angeles, CA
11Karmanos Cancer Institute/ Department of Oncology, Wayne State University, Detroit, MI
12Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, MIAMI, FL

Alexandra E. Rojek, MD1, Benjamin J. McCormick, MD2*, Joanna Cwykiel, MD3*, Oluwatobi Odetola, MD3, Yasmin Abaza, MD3, Rohan Achar, MD, MS4*, Rory M. Shallis, MD4, Danielle Bradshaw, MD5*, Meaghan Standridge, MD6*, Vamsi K. Kota, MD7, Talha Badar, MD2 and Anand Ashwin Patel, MD1

1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
2Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
3Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
4Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
5Georgia Cancer Center, Augusta University Medical Center, Augusta, GA
6Department of Medicine, Augusta University, Augusta, GA
7Georgia Cancer Center, Augusta University, Augusta, GA

Ping Wu, M.D., Ph.D.1*, Wei Ling, M.D.1*, Chengwei Luo, M.D.2*, Xiaomei Chen, M.D., Ph.D.1*, Lisi Huang, M.D.1*, Jinghua Wang, M.D.1*, Peilong Lai, M.D., Ph.D.1*, Suijing Wu, M.D., Ph.D.1*, Xin Du, M.D., Ph.D.1* and Jianyu Weng, M.D., Ph.D.1*

1Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China

Raffaele Palmieri, MD1*, Fabio Guolo, MD, PhD2,3*, Luana Fianchi, MD, PhD4*, Felicetto Ferrara, MD5*, Maria Paola Martelli, MD, PhD6*, Michela Rondoni7*, Capria Saveria8*, Paola Minetto, MD9, Clara Minotti10*, Sofia Sciabolacci11*, Federica Pilo, MD12*, Salvatore Perrone13*, Andrea Corbingi, MD14*, Francesco Grimaldi, MD15*, Giulia De Luca, MD16*, Carla Fili, MD17*, Caterina Alati, MD18*, Francesco Mannelli, MD19*, Federica Lessi, MD20*, Francesco Marchesi21*, Lorenzo Brunetti, MD22*, Debora Capelli, MD23*, Anna Lina Piccioni, MD24*, Calogero Vetro, MD25*, Carla Mazzone, MD26*, Alessandra Sperotto, MD27*, Giovanni Luzi28*, Michelina Dargenio, MD29*, Sabrina Mariani30*, Marco Cerrano, MD31*, Antonino Mulè, MD32*, Ambra Di Veroli, MD33*, Cristina Papayannidis, MD34, Alessandro Isidori, MD, PhD35, Francesco Lanza, MD36*, Michele Gottardi, MD27*, Elisabetta Todisco, MD37*, Livio Pagano, MD4*, Roberto Massimo Lemoli, MD3,38*, Francesco Buccisano, MD, PhD39 and Adriano Venditti, MD39

1Department of Onco-Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
2IRCCS Ospedale Policlinico San Martino, Genoa, Italy
3Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
4Dipartimento di Scienze Radiologiche Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy
5Divisione di Ematologia, Ospedale Cardarelli, Napoli, Italy
6Dipartimento di Medicina e Chirurgia, Hematology, Department of Medicine and Surgey, University of Perugia and "Santa Maria della Misericordia" Hospital, Perugia, ITA
7Hematology Unit & Metropolitan Transplant Network, Ravenna, AUSL Romagna, Ravenna, ITA
8Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy
9Clinica Ematologica, Dipartimento di Oncologia e Ematologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
10Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, ITA
11Hematology, Department of Medicine and Surgey, University of Perugia and "Santa Maria della Misericordia" Hospital, Perugia, Italy
12U.O.C. Ematologia e Trapianto di cellule staminali emopoietiche, A.O. Brotzu, Cagliari, ITA
13Hematology, Polo Universitario Pontino, "Sapienza", Via A. Canova S.M. Goretti Hospital, Latina, Italy
14Hematology, Polo Universitario Pontino, "Sapienza", S.M. Goretti Hospital, Latina, Italy
15Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Naples, ITA
16UOC Ematologia Clinica, Ospedale Civile "Santo Spirito", Pescara, Italy
17Division of Hematology and Stem Cell Transplantation, University Hospital ASUF, Udine, Italy
18U.O.C. Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
19Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
20Divisione di Ematologia e Centro Trapianti, Azienda Ospedaliera Universitaria di Padova, Padova, Italy
21Hematology Unit, IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (I.F.O.), Rome, ITA
22Clinica di Ematologia, Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
23Clinica di Ematologia, Azienda Ospedaliero-Universitaria delle Marche, Ospedali Riuniti di Ancona, Ancona, ITA
24Dipartimento di Ematologia, Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy
25Division of hematology, A.O.U. Policlinico G.Rodolico – S. Marco, Catania, Italy
26Hematology and Stem Cell Transplant Unit, St. Eugenio Hospital, Rome, ITA
27Onco Hematology, Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Castelfranco Veneto, Italy
28Hematology and Stem Cell Transplant, San Camillo Forlanini Hospital, Rome, ITA
29Divisione di Ematologia e Centro Trapianti, CSE Vito Lazzi, Lecce, Italy
30Hematology Unit, Azienda Ospedaliera Universitaria Sant'Andrea, Sapienza University, Rome, ITA
31Division of Hematology, Department of Oncology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
32UOC di Oncoematologia,, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
33Hematology, Belcolle Hospital, Viterbo, Italy
34Istituto di Ematologia "Seràgnoli", IRCCS Azienda Ospedaliero–Universitaria di Bologna, Bologna, Italy
35Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
36Hematology Unit and Metropolitan Romagna Transplant Network, University of Bologna, Ravenna, Italy
37Hematology Department, ASST Valle Olona, Varese, Italy
38Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Italy, Genoa, Italy
39Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

Chezi Ganzel, MD1,2*, Avraham Frisch, MD3,4*, Ofir Wolach, MD5,6*, Yakir Moshe, MD, PhD7,8*, Ellen Broide9*, Emmanuel Benayoun, eranbe@szmc.org.il10*, Jacob M. Rowe, MB, BS11,12,13 and Yishai Ofran, MD14,15

1Hematology Department, Shaare Zedek Medical Center, Jerusalem, Israel
2Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
3Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Rappaport Faculty of Medicine - Technion, Haifa, Israel
4Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
6Rabin Medical Center, Institute of Hematology, Davidoff Cancer Center, Petah Tikva, Israel
7Department of hematology and bone marrow transplantation unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
8Division of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
9Flow cytometry laboratory, Shaare Zedek Medical Center, Jerusalem, Israel
10Flow cytometry laboratory. Shaare Zedek Medical Center, Jerusalem, Israel
11The Ruth and Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel
12Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
13Rambam Health Care Campus Technion, Haifa, Israel
14Department of Hematology and Bone Marrow Transplant, Sharee Zedek Medical Center, Jerusalem, Israel
15Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Juliette Lambert1*, Emmanuel Raffoux, M.D.2*, Delphine Lebon3*, Thorsten Braun, MD, PhD4, Mael Heiblig5*, Alberto Santagostino6*, Karin Gogat-Marchant, PhD7* and Cécile Pautas, MD8*

1Service d’Hématologie Clinique, Centre Hospitalier de Versailles, Le Chesnay-Rocquencourt, France
2Service d’Hématologie Clinique, Hôpital Saint-Louis, Paris, FRA
3Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA
4Hematology Unit, Avicenne Hospital, University Sorbonne Paris Nord, Bobigny, France
5Service d'hématologie clinique, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France
6Service d’Hématologie Clinique, Centre Hospitalier de Troyes, Troyes, France
7Global Clinical Development, Pfizer Inc., Paris, France
8Service d’Hématologie et de Thérapie Cellulaire, Centre Hospitalier Universitaire Henri-Mondor, Creteil, France

Manik Razdan Kuchroo, MD, PhD1*, Robert A. Redd, MS2*, Jacqueline S. Garcia, MD3, Michael Keng, MD4, Gabriela S. Hobbs, MD5, Jacalyn Rosenblatt, MD6, Marlise R. Luskin, MD, MSCE7, Rupa Narayan, MD5, Philip C. Amrein, MD5, Malgorzata McMasters, MD8, Martha Wadleigh, MD7, Hanno Hock, MD, PhD5, Richard Stone7, Donna S. Neuberg, ScD2, David Avigan, MD6, Karen K. Ballen, MD9, Amir T. Fathi, MD5, Daniel J. DeAngelo7 and Andrew M. Brunner, MD5

1Massachusetts General Hospital, Boston, MA
2Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Department of Medicine, Division of Hematology and Oncology, University of Virginia Medical Center Comprehensive Cancer Center, Charlottesville, VA
5Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
6Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
7Dana-Farber Cancer Institute, Boston, MA
8Massachusetts General Hospital, Harvard Medical School, Boston, MA
9University of Virginia Health Center, Charlottesville, VA

Zhangsong Yan1,2*, Yang Li1,2*, Bin Zhang1,2*, Jinsong He1,2*, Jiesi Li1,2*, Shuning Wei1,3*, Qi Wang4,5*, Qiuling Li1,2*, Bo Hu1,2*, Kaiqi Liu2,3* and Yingchang Mi, MD1,2

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
2Tianjin Institutes of Health Science, Tianjin, China
3National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
5State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Melhem M. Solh, MD1, Scott R. Solomon, MD1, Lawrence Morris, MD1, H Kent Holland2*, Lizamarie Bachier-Rodriguez, MD1*, Xu Zhang, PhD3*, Katelin C Jackson1* and Asad Bashey, MD, PhD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2The Blood and Marrow Transplant Program At Northside Hospital, Atlanta, GA
3Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Suravi Raychaudhuri, MD, Ted Gooley, PhD*, Zach Gill*, Allegra Rasmussen*, Anna B. Halpern, MD, Jacob S. Appelbaum, MD, PhD, Cristina Maria Ghiuzeli, MD, Paul C. Hendrie, MD, PhD*, Ryan D Cassaday, MD, Roland B. Walter, MD, PhD, MS, Elihu Estey, MD* and Mary-Elizabeth M. Percival, MD

Fred Hutchinson Cancer Center, Seattle, WA

Ahmed Ibrahim, MD1*, Muhammad Abdullah Yousaf, MBBS, MD1*, Mariam Ikram2*, Huma Khalid1*, . Anum3*, Omar A Safdar4*, Zain Anwer5*, Fatima Faraz1*, Mohammad Rehman, MBBS1* and Muhammad Saad, FCPS6*

1Rawalpindi Medical University, Rawalpindi, Pakistan
2Shifa International Hospital Ltd., Islamabad, Pakistan
3Faisalabad Medical University, Faisalabad, Pakistan
4University of Arizona, Tucson, AZ
5Cleveland Clinic, Cleveland
6Shifa International Hospital, Ltd., Islamabad, Pakistan

Mary Burke, PharmD1*, David A Sallman, MD2, Ariel Denson, PharmD3*, Rebecca Jean Nelson, PharmD3*, Onyee Chan, MD4*, Alison R. Walker, MD, MPH, MBA4, Eric Padron, MD4, Zhuoer Xie, MD, MS4, Rami S. Komrokji, MD4, Jeffrey Lancet, MD4, Andrew T. Kuykendall, MD4, Katherine Tobon, PharmD3*, Akriti Gupta Jain, MD5, Chen Wang, MD, PhD5* and Najla H Al Ali, MS4,5*

1Moffitt Cancer Center, Tampa, FL
2H. Lee Moffitt Cancer Center, Tampa, FL
3Department of Pharmacy, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
5Moffitt Cancer Center, Tampa

Shengqin Cheng1*, Li Gao1*, Yi Wang1*, Peifang Xiao1*, Hailong He1*, Jun Lu1*, Jie Li1*, Yixin Hu1*, Liyan Fan1*, Raul C. Ribeiro, MD2, Cheng Cheng3* and Shaoyan Hu, MD, PhD1

1Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
2Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
3Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN

Xiaonan Lin1*, Yuming Zhang2*, Ying Zhao3*, Ying Dong4*, Xiaotao Wang5*, Pengcheng Huang6*, Zhenqian Huang, Ph.D.7*, Honghua He2*, Xiaoli Xu3*, Yaya Wang7*, Fang Jiang5*, Hui Zeng8, Rui Huang, MD9* and Yuhua Li10*

1Department of Hematology, Zhujiang hospital of Southern Medical University, Guangzhou, Guangdong province, China
2Department of Hematology, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
3Department of Hematology, The First People’s Hospital of Foshan, Foshan, China
4Department of Hematology, Maoming People’s Hospital, Maoming, China
5Department of Hematology, Affiliated Hospital of Guilin Medical University, Guilin, China
6Department of Hematology, Zhaoqing the First People’s Hospital, Zhaoqing, China
7Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
8Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong province, China
9Department of Hematology, Zhujiang Hospital, Southern Medical University, GUANGZHOU, AL, China
10Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China

Yali Liang1*, Sarah F Cook2*, Ronald Cheung3, Honghui Zhou1, Sheryl Coppola1*, Qi Wang1,4*, Donald E Mager2,5* and Scott A Van Wart2*

1Jazz Pharmaceuticals, Philadelphia, PA
2Enhanced Pharmacodynamics, LLC (ePD), Buffalo, NY
3Jazz Pharmaceuticals, Palo Alto, CA
4Enliven Therapeutics, Boulder, CO
5Department of Pharmaceutical Sciences, University at Buffalo, SUNY, Buffalo, NY

Georgina Gener-Ricos1*, Gautam Borthakur, MD1, Koji Sasaki, MD1, Guilin Tang, MD, PhD2*, Guillermo Montalban-Bravo, MD1, Elias Jabbour1, Maro Ohanian, DO1*, Musa Yilmaz, MD1*, Fadi G. Haddad, MD1*, Kelly S. Chien, MD1, Jo Ishizawa, MD, PhD1, Nicholas J. Short, MD1, Abhishek Maiti, MD1, Mahesh Swaminathan, MD1, Guillermo Garcia-Manero, MD3, Naval Daver, MD1, Courtney D. DiNardo, MD, MSc1, Farhad Ravandi, MD, MBBS1 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Texas MD Anderson Cancer Center, Houston, TX

Stephanie Boisclair, MD1, Phyu Thin Naing, MBBS2, Edward Zhou, MD3, Richa Thakur, MD2, Bradley Goldberg, MD4, Erin Jou, MD4, David W Chitty, DO, MSc5 and Jonathan E Kolitz, MD6

1Northwell Health, Bellerose, NY
2Zuckerberg Cancer Center, Rego Park, NY
3Zuckerberg Cancer Center, New Hyde Park, NY
4Zuckerberg Cancer Center, Lake Success, NY
5Zuckerberg Cancer Center, Northwell Health, New Hyde Park, NY
6Zucker School of Medicine at Hofstra/Northwell, Zuckerberg Cancer Center, Lake Success, NY

Liyan Fan1*, Hua Jiang, MD PhD2*, Hongjun Liu, MD3*, Ning Liao, MD4*, Ningling Wang, MD5*, Xiaowen Zhai, MD PhD6*, Xiuli Ju, MD PhD7*, Yufeng Liu, MD PhD8*, Jixia Luo, MD9*, Peifang Xiao1*, Jun Lu1*, Hailong He1*, Yi Wang1*, Raul C. Ribeiro, MD10 and Shaoyan Hu, MD, PhD1

1Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China
2Department of Hematology and Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, China
3Department of Hematology and Oncology, Anhui Provincial Hospital, University of Science and Technology of China, Hefei, China
4Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
5Department of Hematology and Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China
6Department of Hematology and Oncology, Children's Hospital of Fudan University, Shanghai, China
7Department of Hematology and Oncology, Qilu Hospital of Shandong University, Qingdao, China
8Department of Hematology and Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
9Department of Hematology and Oncology, Kaifeng Children's Hospital, Kaifeng, China
10Division of Leukemia/Lymphoma, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

*signifies non-member of ASH